MaryColleen(Pinder)Pinder-SchenckMD

PubMed

• 29 citations
  CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition
  Priya K. Gopalan, Andres Gordillo Villegas, Chunxia Cao, Mary Pinder-Schenck, Alberto Chiappori, Wei Hou, Maria Zajac-Kaye, Alison Marguerite Ivey, Frederic J. Kaye> ;Oncotarget. 2018 Dec 21
• 18 citations
  A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
  Jhanelle E. Gray, Alberto Chiappori, Charles Williams, Tawee Tanvetyanon, Eric B. Haura, Ben C. Creelan, Jongphil Kim, Theresa A. Boyle, Mary Pinder-Schenck, Farah Kha...> ;Cancer Immunology, Immunotherapy. 2018 Sep 12
• 11 citations
  Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
  Clara Y.H. Choi, Heather A. Wakelee, Joel W. Neal, Mary Pinder-Schenck, Hsiang Hsuan Michael Yu, Steven D. Chang, John R. Adler, Griffith R. Harsh, Scott G. Soltys> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Nov 1
• 45 citations
  Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer
  Giorgio V. Scagliotti, Jin Hyoung Kang, David J. Smith, Richard K. Rosenberg, Keunchil Park, Sang We Kim, Wu Chou Su, Thomas E. Boyd, Donald A. Richards, Silvia Novell...> ;Investigational New Drugs. 2016 Jun 27
• 961 citations
  Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell...
  Scott N. Gettinger, Leora Horn, Leena Gandhi, David R. Spigel, Scott J. Antonia, Naiyer A. Rizvi, John D. Powderly, Rebecca S. Heist, Richard D. Carvajal, David M. Jac...> ;Journal of Clinical Oncology. 2015 Apr 20
• 10 citations
  Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patien...
  Thomas J. Dilling, Martine Extermann, Jongphil Kim, Lora M. A. Thompson, Binglin Yue, Craig Stevens, Scott J. Antonia, Jhanelle E. Gray, Charles Williams, Eric B. Haur...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Nov 15
• 22 citations
  Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment...
  Ronald B. Natale, Fiona H Blackhall, Dariusz M. Kowalski, Rodryg Ramlau, Gerold Bepler, Francesco Grossi, Christian A. Lerchenmuller, Mary Pinder-Schenck, J. Mezger, S...> ;Journal of Thoracic Oncology. 2014 Nov 1
• 40 citations
  A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.
  Jhanelle E. Gray, Eric B. Haura, Alberto Chiappori, Tawee Tanvetyanon, Charles C. Williams, Mary Pinder-Schenck, Julie A. Kish, Jenny Kreahling, Richard Lush, Anthony ...> ;Clinical Cancer Research. 2014 Mar 15
• 20 citations
  Systemic and Targeted Therapies for Early-Stage Lung Cancer:
  Elizabeth Byron, Mary Pinder-Schenck> ;Cancer Control. 2014 Jan 1
• 113 citations
  Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
  Gerold Bepler, Charles Williams, Michael J. Schell, Wei Chen, Zhong Zheng, George R. Simon, Shirish M. Gadgeel, Xiuhua Zhao, Fred Schreiber, Julie R. Brahmer, Alberto ...> ;Journal of Clinical Oncology. 2013 Jul 1
• 313 citations
  Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines
  David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Ramaswamy Govindan, Fre...> ;Journal of the National Comprehensive Cancer Network. 2013 Jun 1
• Adapting to the brave new world of lung cancer treatment.
  Mary Pinder-Schenck, Scott J. Antonia> ;Oncology. 2013 May 1
• 55 citations
  Thymomas and thymic carcinomas
  David S. Ettinger, Gregory J. Riely, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Ramas...> ;Journal of the National Comprehensive Cancer Network. 2013 May 1
• 56 citations
  The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement
  Renato G. Martins, Thomas A. D'Amico, Billy W. Loo, Mary Pinder-Schenck, Hossein Borghaei, Jamie E. Chaft, Apar Kishor Ganti, Feng-Ming Spring Kong, Mark G. Kris, Inga...> ;Journal of the National Comprehensive Cancer Network. 2012 May 1
• 40 citations
  Characteristics and correlates of sleep disturbances in cancer patients
  Kristin M. Phillips, Heather S.L. Jim, Kristine A. Donovan, Mary C. Pinder-Schenck, Paul B. Jacobsen> ;Supportive Care in Cancer. 2012 Feb 1
• 76 citations
  Malignant pleural mesothelioma.
  David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Apar Kishor Ganti, Rama...> ;Journal of the National Comprehensive Cancer Network. 2012 Jan 1
• 424 citations
  Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer
  Mary Colleen Pinder, Zhigang Duan, James S. Goodwin, Gabriel N. Hortobagyi, Sharon H. Giordano> ;Journal of Clinical Oncology. 2007 Sep 1
• 12 citations
  Nanoparticle albumin-bound paclitaxel for treatment of metastatic breast cancer.
  Mary Colleen Pinder, Nuhad K. Ibrahim> ;Drugs of Today. 2006 Sep 1
• 1 citations
  Neoadjuvant chemotherapy for non-small cell lung cancer.
  M Pinder-Schenck, G Bepler> ;Minerva Chirurgica. 2009 Dec 1
• Join now to see all